Search clinical trials for: Maxigesic® IV

Total 16740 results

AFT Pharmaceuticals, Ltd.

Completed

Maxigesic® IV Phase 3 Exposure Study

Postoperative Pain

United States, New Zealand
AFT Pharmaceuticals, Ltd.

Completed

Maxigesic IV Phase 3 Bunionectomy Study

Post Operative Pain

United States
Ajou University School of Medicine

Not yet recruiting

The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement

Opioid Use

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Prevention of Maternal Hypothermia After Scheduled Caesarean Section Using Active Intravenous Warming (CESAR-RESOL2)

Postoperative Hypothermia

France
Smiths Medical, ASD, Inc.

Completed

A Study Evaluating the Clinical Performance of the ViaValve™ Safety IV Catheter (ViaValve-001)

Peripheral Intravenous Catheter

Canada
AFT Pharmaceuticals, Ltd.

Withdrawn

Maxi-Analgesic Phase 2 Study to Compare the Analgesic Effects in Different Dosing Groups to Treat Teeth Extraction Pain

Dental Pain

United States
AFT Pharmaceuticals, Ltd.

Completed

Maxigesic 325 Acute Dental Pain Study

Dental Pain

United States, New Zealand
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

3-Tesla MRI Response to TACE in HCC (Liver Cancer)

Advanced Adult Primary Liver Cancer | Localized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma | Stage A Adult Primary Liver Cancer (BCLC) | Stage B Adult Primary Liver Cancer (BCLC)

United States
Lazarski University
Poznan University of Medical Sciences; Wroclaw Medical University; Medical University...

Completed

Intravascular Access in Suspected/Confirmed COVID-19 Patient

Shock | Emergency Medicine | Cardiopulmonary Arrest

Poland
Foundation for Innovative New Diagnostics, Switzerland

Completed

DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV

Hepatitis C Virus Infection

Ukraine
University of Illinois at Chicago
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction (TIN-PCOS-AOD)

Polycystic Ovary Syndrome

United States
National Taiwan University Hospital
Ministry of Science and Technology, Taiwan; Teleflex

Completed

Venous Injection Compared To intraOsseous Injection During Resuscitation of Patients With Out-of-hospital Cardiac Arrest (VICTOR)

Vascular Access | Out-of-Hospital Cardiac Arrest | Intraosseous Access | Emergency Medical Service | Intravenous Access

Taiwan
Syros Pharmaceuticals

Suspended

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia

United States
Nantes University Hospital
Direction Générale de l'Offre de Soins

Completed

CCA of SGB PCR Versus SGB Culture at 35-38 SA in the Optimization of Intrapartum Antibiotic Prophylaxis (DEPIST2P)

Streptococcus Agalactiae

France
Yonsei University

Recruiting

Analgesic Efficacy of Maxigesic in Breast Cancer Surgery

Breast Cancer

Korea, Republic of
The University of Texas Medical Branch, Galveston
Mallinckrodt

Withdrawn

Effects of Intravenous Acetaminophen in Patients Undergoing Thoracoscopic Surgery (IVTylenol)

Post-thoracotomy Pain Syndrome
Wake Forest University Health Sciences

Completed

Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury

Total Parenteral Nutrition-induced Cholestasis

United States
University Hospital, Ghent

Completed

Comparison of Tramadol Orally Versus an Optimized Dose of Intravenous Tramadol for Postoperative Pain Relief in Ambulatory Surgery

Pain

Belgium
Rempex (a wholly owned subsidiary of Melinta Therapeutics...

Completed

A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting

Gram-Negative Bacterial Infections

United States
Nantes University Hospital

Completed

Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens (FB4-PEDIA)

Hematologic Malignancy

France
Amgen

Completed

Darbepoetin Alfa With or Without Intravenous (IV) Iron

Anemia | Non-Myeloid Malignancies
Becton, Dickinson and Company

Completed

Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Contrast Enhanced CT Scans (ARCTR05)

Contrast Enhanced Computed Tomography

United States
Franklin Health Research

Active, not recruiting

IV Administration of ChromaDex's Niagen® as Compared to NAD+

Healthy Aging

United States
Taipei City Hospital

Not yet recruiting

TCHCCT-Zhong-Xing-Emergency-Department Ultrasound With IV Contrast in Acute Flank Pain

Acute Flank Pain

Taiwan
University of Michigan

Completed

Glucocorticoid Administration After Traumatic Birth

Traumatic Birth

United States
Hoffmann-La Roche

Completed

A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer (PHranceSCa)

HER2-Positive Early Breast Cancer

United States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
Eli Lilly and Company

Completed

A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis

Psoriasis

United States
Healthgen Biotechnology Corp.

Recruiting

Study of OsrhAAT or Placebo in Healthy Volunteers

Emphysema Secondary to Congenital AATD

United States
Kyowa Kirin Co., Ltd.

Terminated

Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis

Atopic Dermatitis

Japan
Healthgen Biotechnology Corp.

Completed

A Study of OsrHSA in Adult Healthy Male and Female Volunteers

Ascites Hepatic

United States
King Edward Medical University

Completed

Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two.

Burns

Pakistan
Eli Lilly and Company

Completed

A Study of LY3002813 in Participants With Alzheimer's Disease

Alzheimer Disease

United States, Japan
Asir John Samuel
Maharishi Markendeswar University (Deemed to be University)

Recruiting

Class IV Laser Therapy on Ejection Fraction, Cardio Biomarkers and Functional Outcomes

Acute Coronary Syndrome

India
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects

Infections, Bacterial

United States
Joseph Broderick
Medical University of South Carolina; National Institute of Neurological Disorders... and other collaborators

Terminated

Interventional Management of Stroke (IMS) III Trial (IMSIII)

Stroke

Canada, United States, Switzerland, Germany, Spain, Netherlands, Australia, France
Wockhardt

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771

Bioavailability

United States
C. R. Bard

Completed

AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use

Vascular Access Complication

United States
Prometheus Biosciences, Inc., a subsidiary of Merck...
Altasciences Company Inc.

Completed

Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023

Healthy

United States
Eli Lilly and Company

Completed

A Study of LY3475766 in Healthy Participants

Dyslipidemias

United States
Pfizer

Completed

Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia

Community-Acquired Pneumonia (CAP)

United States, Canada, Germany, Greece, Spain
Flame Biosciences

Withdrawn

Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors

Gastric Cancer | Solid Tumor | Pancreas Cancer
Oculis
Neurotrials

Recruiting

OCS-05 in Patients With Acute Optic Neuritis (ACUITY)

Optic Neuritis | Optic; Neuritis, With Demyelination

France
University of Arizona
Emory University; National Center for Complementary and Integrative Health...

Withdrawn

Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes

Hepatitis C

United States
Gmax Biopharm LLC.

Recruiting

A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

United States, China
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)

Type 2 Diabetes Mellitus
Qilu Pharmaceutical Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)

Healthy

China
Bayer

Recruiting

A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)

Pulmonary Hypertension Due to Left Heart Disease

Germany
Alexion Pharmaceuticals, Inc.
Syneos Health

Completed

Study of ALXN1820 in Healthy Adult Participants

Healthy

Australia, United Kingdom
Eli Lilly and Company

Completed

A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants

Healthy

United States
Eli Lilly and Company

Completed

A Study of LY3361237 in Healthy Participants

Healthy

United States

Search clinical trials for: Maxigesic® IV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations